Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Market Cap	11.10B -43.7%
Revenue (ttm)	4.20B -0.6%
Net Income	1.04B -2.1%
EPS	12.26 -2.2%
Shares Out	84.72M
PE Ratio	10.69
Forward PE	9.72
Dividend	7.75 (5.92%)
Ex-Dividend Date	Mar 26, 2026

Volume	158,464
Average Volume	267,709
Open	131.00
Previous Close	131.50
Day's Range	130.00 - 132.00
52-Week Range	129.50 - 219.50
Beta	0.35
RSI	35.83
Earnings Date	May 8, 2026

About TPEX:3218

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical instruments , eyeglasses, contact lenses and eyeglass accessories. It is also involved in eyeglasses optometry and dispensing services; and leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy analysis, as well as provides medical optometry scientific glasses; sunglasses, fashion boutique glasses, and progressive lenses for presbyopia; and contact lenses f...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3218

Financial Performance

In 2025, TPEX:3218's revenue was 4.20 billion, a decrease of -0.57% compared to the previous year's 4.23 billion. Earnings were 1.04 billion, a decrease of -2.07%.